Salud financiera de hoja de balance de Elevance Health
Salud financiera controles de criterios 5/6
Elevance Health tiene un patrimonio de accionistas total de $40.7B y una deuda total de $26.5B, lo que sitúa su ratio deuda-patrimonio en 65%. Sus activos y pasivos totales son $111.9B y $71.2B respectivamente. El BAIT de Elevance Health es de $10.2B, por lo que su ratio de cobertura de intereses es de 9.8. Tiene efectivo e inversiones a corto plazo que ascienden a $36.3B.
Información clave
65.0%
Ratio deuda-patrimonio
US$26.45b
Deuda
| Ratio de cobertura de intereses | 9.8x |
| Efectivo | US$36.27b |
| Patrimonio | US$40.71b |
| Total pasivo | US$71.18b |
| Activos totales | US$111.89b |
Actualizaciones recientes sobre salud financiera
Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16
Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Recent updates
Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?
Nov 16Elevance Health to acquire speciality pharmacy from CarepathRx
Nov 09Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price
Nov 02Elevance Health declares $1.28 dividend
Oct 19Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?
Oct 12Elevance affiliates to offer affordable Medicare Advantage plans
Oct 10Molina, Elevance, Centene win Medicare contracts in California
Aug 26Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Aug 25Elevance Health: Continues To Grow, A Strong Buy
Aug 18What Does Elevance Health Inc.'s (NYSE:ELV) Share Price Indicate?
Aug 13Elevance Health (NYSE:ELV) Shareholders Will Want The ROCE Trajectory To Continue
Aug 01Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($60.9B) de ELV superan a sus pasivos a corto plazo ($44.3B).
Pasivo a largo plazo: Los activos a corto plazo de ELV ($60.9B) superan a sus pasivos a largo plazo ($26.9B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ELV tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ELV ha pasado de 66.4% a 65% en los últimos 5 años.
Cobertura de la deuda: La deuda de ELV no está bien cubierta por el flujo de caja operativo (13.5%).
Cobertura de intereses: Los pagos de intereses de la deuda de ELV están bien cubiertos por el BAIT (9.8x cobertura).